Overactive Bladder - Results from #1200

Is mirabegron equally as effective when used as first- or second-line therapy in women with overactive bladder? December 21, 2016

Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study December 21, 2016

Electrical stimulation with non-implanted electrodes for overactive bladder in adults December 14, 2016

Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer December 14, 2016

Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population December 14, 2016

Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study December 14, 2016

Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial December 7, 2016

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder December 7, 2016

Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People December 7, 2016

Feasibility of Long-Term Tibial Nerve Stimulation Using a Multi-Contact and Wirelessly-Powered Neurostimulation System Implanted in Rats December 7, 2016

Urinary retention in female OAB after intravesical Botox injection: who is really at risk? November 30, 2016

Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis November 30, 2016

Anticholinergics for overactive bladder: Temporal trends in prescription and treatment persistence November 30, 2016

No immediate effect on urodynamic parameters during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder and daytime incontinence-A randomized, double-blind, placebo-controlled study November 30, 2016

The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial November 29, 2016

Changes in intraocular pressure and tear secretion in patients given 5 mg solifenacin for the treatment of overactive bladder. November 24, 2016

Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females November 22, 2016

Urinary imidafenacin contributes to the long-lasting blockade of bladder muscarinic receptors: Effects of bilateral ligation of ureters November 14, 2016

Urethral Pressure Variation: A neglected contributing factor in patients with overactive bladder syndrome? November 14, 2016

Perivaginal benign masses: diagnosis and therapy in a series of 66 women November 12, 2016

Page 61 of 122